5 References 1. James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nature Reviews Molecular Cell Biology. 2021; 22: 751– 771 doi: 10.1038/s41580-021-00390-6. 2. Collaborators G2D. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023; 402: 203– 234 doi: 10.1016/s0140-6736(23)01301-6. 3. Cunha-Guimaraes JP, Guarino MP, Timoteo AT, Caires I, Sacramento JF, Ribeiro MJ, Selas M, Santiago JCP, Mota-Carmo M, Conde SV. Carotid body chemosensitivity: early biomarker of dysmetabolism in humans. European Journal of Endocrinology. 2020; 182: 549–557 doi: 10.1530/EJE-19-0976. 4. Ribeiro MJ, Sacramento JF, Gonzalez C, Guarino MP, Monteiro EC, Conde SV. Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets. Diabetes. 2013; 62: 2905– 16 doi: 10.2337/db12-1463. 5. Schlaich M, Straznicky N, Lambert E, Lambert G. Metabolic syndrome: a sympathetic disease? The Lancet Diabetes Endocrinology. 2015; 3: 148–57 doi: 10.1016/S2213-8587(14)70033-6. 6. Kumar P, Prabhakar NR. Peripheral chemoreceptors: function and plasticity of the carotid body. 2012; 2: 141–219 doi: 10.1002/cphy.c100069. 7. Limberg JK. Glucose, insulin, and the carotid body chemoreceptors in humans. Physiological Genomics. 2018; 50: 504–509 doi: 10.1152/physiolgenomics.00032.2018. 115
RkJQdWJsaXNoZXIy MTk4NDMw